Trial Profile

A phase II/III study of EscharEx in Diabetic Foot Ulcers

Status: Planning

Phase of Trial: Phase II/III

Latest Information Update: 30 Mar 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs EscharEx (Primary)
Indications Diabetic foot ulcer
Focus Therapeutic Use

Most Recent Events

19 Mar 2025 According to a MediWound media release, the company has obtained 16.5 million Euros in European Innovation Council (EIC) funding to accelerate the development of EscharEx for treating diabetic foot ulcers (DFUs), including this trial.
12 Feb 2025 According to a MediWound media release, company expected to begin this trial in 2026.
30 Jul 2024 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com